During the past decade, General Hospital Sibenik conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Sibenik" #1 sponsor was "Kartos Therapeutics, Inc." with 1 trials, followed by "Mylan Pharmaceuticals Inc" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Pharming Technologies B.V." with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Sibenik" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Sibenik" are "Hereditary Angioedema" (2 trials), "Lactation" (1 trials), "NSCLC Stage IV" (1 trials), "Post-Essential Thrombocythemia MF (Post-ET-MF)" (1 trials) and "Post-Polycythemia Vera MF (Post-PV-MF)" (1 trials). Many other conditions were trialed in "General Hospital Sibenik" in a lesser frequency.

Most popular intervention types in "General Hospital Sibenik" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Best Available Therapy (BAT)" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials), "KRT-232" (1 trials) and "rhC1INH or pdC1INH" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Sibenik" are 5 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Sibenik". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in General Hospital Sibenik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Sibenik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".